Boston Scientific Corporation
Boston Scientific Corporation’s Price-to-Book Ratio at a glance
Boston Scientific Corporation reports price-to-book ratio of 6x for Dec 2024. The prior period recorded 4.4x (Dec 2023). Year over year the metric moved +1.68 (+38.6%). The rolling three-period average stands at 4.7x. Data last refreshed Dec 18, 2025, 10:13 AM.
Latest reading
6x · Dec 2024
YoY movement
+1.68 (+38.6%)
Rolling average
4.7x
Current Price-to-Book Ratio
6x
+1.68
+38.6%
Rolling average
4.7x
Latest Value
6x
Dec 2024
YoY Change
+1.68
Absolute
YoY Change %
+38.6%
Rate of change
3-Period Avg
4.7x
Smoothed
Narrative signal
Boston Scientific Corporation’s price-to-book ratio stands at 6x for Dec 2024. Year-over-year, the metric shifted by +1.68, translating into a +38.6% rate of change versus the prior period.
Pair this momentum with product cadence, pricing power, and capital allocation moves to understand durability.
Blend with balance sheet, cash flow, and peer benchmarks from AlphaPilot’s broader dashboards to shape an investable thesis.
How price-to-book ratio shapes Boston Scientific Corporation's story
As of Dec 2024, Boston Scientific Corporation reports price-to-book ratio of 6x. Monitor price-to-book trends to gauge how investors value tangible assets and equity on the balance sheet.
Capital-intensive industries
Banks, insurers, and industrials rely on P/B to judge returns on equity relative to book value.
Reading discount or premium
Ratios below 1.0 signal the market values equity below book, which could mean undervaluation or weak profitability.
Valuation Multiples
Compare how the market prices revenue, equity, and operating cash flow versus peers and history.
Profitability & Margins
Understand cost structure and capital efficiency trends across gross, operating, and net results.
Gross Margin
61.3%
Operating Margin
15.7%
Net Profit Margin
11.1%
Return on Equity
8.5%
Return on Assets
4.7%
Growth Momentum
Track whether top-line, earnings, and free cash flow growth are accelerating or cooling.
Balance Sheet Strength
Evaluate leverage, liquidity, and cash generation capacity that underpin resilience.
Shareholder Returns
Follow dividend sustainability and cash generation relative to market value.
Boston Scientific Corporation (BSX) FAQs
Answers tailored to Boston Scientific Corporation’s price-to-book ratio profile using the latest Financial Modeling Prep data.
What is Boston Scientific Corporation's current price-to-book ratio?
As of Dec 2024, Boston Scientific Corporation reports price-to-book ratio of 6x. This reading reflects the latest filings and price data for BSX.
How is Boston Scientific Corporation's price-to-book ratio trending year over year?
Year-over-year, the figure shifts by +1.68 (+38.6%). Pair this context with revenue growth and free cash flow signals to gauge momentum for BSX.
Why does price-to-book ratio matter for Boston Scientific Corporation?
Price-to-book compares market value with book value of equity, highlighting balance sheet-driven valuation. For Boston Scientific Corporation, operating within Healthcare — Medical - Devices, tracking this metric helps benchmark management's execution against close competitors.
Is Boston Scientific Corporation's price-to-book ratio above its recent average?
Boston Scientific Corporation's rolling three-period average sits at 4.7x. Comparing the latest reading of 6x to that baseline highlights whether momentum is building or fading for BSX.
How frequently is Boston Scientific Corporation's price-to-book ratio refreshed?
Data for BSX was last refreshed on Dec 18, 2025, 10:13 AM and updates automatically every 24 hours, keeping your valuation inputs current.